LBT report part 2

File Info : application/pdf, 30 Pages, 1.28MB

Array
(
    [0] => Array
        (
            [url_sha] => 8dc04ba78d4d1de6f906d858034a46b0746ad9fd6a7287e9e7e0ef62a6f4c02b
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=3439964
            [href_text] => LBT report part 2
            [href_description] => Boston Scientific Corporation CRM330017 3300 ESCCRM330017 ESCCRM330017 crm330017
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=3439964
            [http_size] => 1338899
            [file_sha256] => 691c93d99b30da73bd54f581b96251fd171d524c05d93ae79ac0b9737bbc36bf
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 3439964
            [file_sha256] => 
            [applicationId] => 8aCPu/TvJE0QIRP1uOyJrA==
            [description] => LBT report part 2
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Test Report
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 1341781
            [submissionDate] => 2017-06-26 00:00:00
            [dateAvailable] => 2017-09-13 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => ESCCRM330017
            [cleanFccId] => ESCCRM330017
            [exif] => 0
        )

)